ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,535Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 387

$1.69M Total Retail Price of All Prescriptions

Rank: 7 out of 387

467 Patients Receiving at Least One Drug in Part D
42%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

56% of this provider’s 467 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

49% of this provider’s 467 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

4% of this provider’s 7,438 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$86 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 1,482 536 S3 1 1
OXYCODONE HCL 1,010 318 S2 2 71
MORPHINE SULFATE ER 634 158 S2 3 79
LISINOPRIL 532 213 4 3
FENTANYL 489 144 S2 5 80
MORPHINE SULFATE 486 92 S2 6 174
OXYCONTIN 456 98 S2 7 92
OMEPRAZOLE 448 155 8 4
GABAPENTIN 432 147 9 10
FUROSEMIDE 360 179 10 7
LEVOTHYROXINE SODIUM 308 173 11 2
MELOXICAM 300 125 12 22
METFORMIN HCL 298 120 13 8
ZOLPIDEM TARTRATE 293 94 14 16
SIMVASTATIN 285 123 15 5
TIZANIDINE HCL 272 50 16 127
CYCLOBENZAPRINE HCL 246 61 R 17 42
TRAZODONE HCL 232 79 18 37
CLONIDINE HCL 221 106 19 38
POTASSIUM CHLORIDE 221 112 19 9
METHADONE HCL 211 56 S2 21 202
TRAMADOL HCL 196 41 22 14
LYRICA 187 31 23 66
ALLOPURINOL 171 102 24 28
AMOXICILLIN 154 53 25 177
PROMETHAZINE HCL 147 45 R 26 82
METOPROLOL SUCCINATE 143 69 27 18
AMLODIPINE BESYLATE 141 73 28 6
CILOSTAZOL 141 85 28 218
JANUVIA 138 99 30 60
ATORVASTATIN CALCIUM 133 56 31 13
NEXIUM 129 52 32 26
RANITIDINE HCL 127 36 33 45
AMITRIPTYLINE HCL 126 34 R 34 62
PAROXETINE HCL 125 60 35 52
NAMENDA 124 91 36 35
CITALOPRAM HBR 124 52 36 19
OXYCODONE HCL-ACETAMINOPHEN 120 49 S2 38 98
IBUPROFEN 114 0 39 85
SULFAMETHOXAZOLE-TRIMETHOPRIM 112 46 40 90
CARISOPRODOL 109 15 R 41 53
VENTOLIN HFA 109 36 41 142
HYDROMORPHONE HCL 109 11 S2 41 273
CLOPIDOGREL 108 74 44 25
CYMBALTA 107 19 45 44
TOPIRAMATE 107 13 45 140
DOXYCYCLINE HYCLATE 107 64 45 114
SPIRONOLACTONE 106 65 48 67
VOLTAREN 103 40 49 220
ROPINIROLE HCL 101 31 50 91
ATENOLOL 98 45 51 20
PROAIR HFA 96 50 52 47
HYDROCHLOROTHIAZIDE 95 55 53 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 55 54 30
SINGULAIR 88 50 55 83
METOPROLOL TARTRATE 87 50 56 11
ESTRADIOL 85 39 R 57 105
ENDOCET 83 15 S2 58 147
HALOPERIDOL 82 11 59 253
FLUOXETINE HCL 78 25 60 46
BYSTOLIC 75 15 61 112
PRAVASTATIN SODIUM 72 32 62 15
PLAVIX 69 40 63 39
POLYETHYLENE GLYCOL 3350 67 34 64 57
SPIRIVA 65 12 65 61
VENLAFAXINE HCL ER 65 0 65 97
LANTUS 64 33 67 51
ACETAMINOPHEN-CODEINE 62 36 S3 68 155
PHENYTOIN SODIUM EXTENDED 62 24 68 107
BUMETANIDE 61 40 70 247
CARVEDILOL 61 37 70 21
ACTOS 61 27 70 99
DONEPEZIL HCL 60 43 73 27
ADVAIR DISKUS 60 44 73 41
LIDODERM 59 0 75 217
CIPROFLOXACIN HCL 59 39 75 56
LIDOCAINE 58 16 77 352
DOXAZOSIN MESYLATE 58 46 77 75
LAMOTRIGINE 58 0 77 138
PREDNISONE 57 23 80 43
AZITHROMYCIN 52 26 81 49
WARFARIN SODIUM 51 29 82 17
OXYCODONE-ACETAMINOPHEN 50 11 S2 83 203
GLYBURIDE 50 35 R 83 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.